Brian K. Dieckgraefe

Brian K. Dieckgraefe, MD, PhD

  • Gastroenterology

Sees Patients For

Crohn's disease, inflammatory bowel disease

Patients Seen At

Hospital Affiliations

  • Barnes-Jewish Hospital
  • VA Medical Center - St. Louis

Board Certifications

  • Internal Medicine Certified
  • Gastroenterology Certified

Academic Title(s)

Associate Professor, Medicine
Division of Gastroenterology

Chief of Gastroenterology
St. Louis VA Medical Centers

Languages

  • English

Education

Medical Degree

1988 Washington University School of Medicine, St. Louis, Missouri

Ph.D.

1988 Biological Sciences, Washington University, St. Louis, Missouri

B.A.

1982 Microbiology, University of Kansas, Lawrence, Kansas

Publications & Research

Search PubMed for publications »

Financial Disclosures

Disclosure of Financial Interests with Industry

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Company Name: AvexlRoyalties: $1 - $9,999Equity: YesConsulting/Advisory Board: $1 - $9,999Speaker Fees: $1 - $9,999Reporting Date: 05/01/2021
Company Name: Roche PharmaceuticalsRoyalties: $1 - $9,999Consulting/Advisory Board: $1 - $9,999Speaker Fees: $1 - $9,999Reporting Date: 05/01/2021
Company Name: Avexi PharmaceuticalRoyalties: $1 - $9,999Equity: YesConsulting/Advisory Board: $1 - $9,999Speaker Fees: $1 - $9,999Reporting Date: 05/01/2021